Autologous Mesenchymal Stem Cells Show More Benefit on Systolic Function Compared to Bone Marrow Mononuclear Cells in a Porcine Model of Chronic Myocardial Infarction
Open Access
- 17 September 2015
- journal article
- research article
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 8 (7) , 393-403
Abstract
Cardiac cell therapy is a strategy to treat patients with chronic myocardial infarction (MI). No consensus exists regarding the optimal cell type. First, a comparison between autologous bone marrow-derived mononuclear cells (BMMNC) and mesenchymal stem cells (MSC) on therapeutic efficacy after MI was performed. Next, the effect of repetitive, NOGA-guided transendocardial injection was determined via a crossover design. Nineteen pigs were allocated in three groups: (1) placebo (at 4 and 8 weeks), (2) MSC (followed by placebo at 8 weeks), or (3) BMMNC (followed by MSC at 8 weeks) delivery including a priming strategy to enhance MSC effect. At 4 weeks, ejection fraction (EF) was significantly improved after MSC injection and not by BMMNC injection. After 8 weeks, no difference was observed in EF between cell-treated groups demonstrating the positive systolic effect of MSC. This study showed that MSC rather than BMMNC injection improves systolic function in chronic MI.Keywords
This publication has 30 references indexed in Scilit:
- Adult Bone Marrow Cell Therapy Improves Survival and Induces Long-Term Improvement in Cardiac ParametersCirculation, 2012
- Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantationJournal of Cellular and Molecular Medicine, 2012
- Transendocardial cell injection is not superior to intracoronary infusion in a porcine model of ischaemic cardiomyopathy: a study on delivery efficiencyJournal of Cellular and Molecular Medicine, 2012
- Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart diseaseCardiovascular Research, 2011
- Intramyocardial Bone Marrow Cell Injection for Chronic Myocardial IschemiaJAMA, 2009
- Exenatide Reduces Infarct Size and Improves Cardiac Function in a Porcine Model of Ischemia and Reperfusion InjuryJACC, 2009
- Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarctionJournal of Molecular and Cellular Cardiology, 2008
- Heart Disease and Stroke Statistics—2008 UpdateCirculation, 2008
- Adult Bone Marrow–Derived Cells for Cardiac RepairArchives of internal medicine (1960), 2007
- Nonfluoroscopic, in vivo navigation and mapping technologyNature Medicine, 1996